<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Epidemiology and Public Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/99CD1473-8294-46F6-9A06-BF37957F351B"><gtr:id>99CD1473-8294-46F6-9A06-BF37957F351B</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Vaclav</gtr:otherNames><gtr:surname>Holmes</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802432"><gtr:id>77063CA9-4E73-4BE2-A5C3-0DCA1EDD3001</gtr:id><gtr:title>Public health applications of cardiovascular genomics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802432</gtr:grantReference><gtr:abstractText>Heart disease and stroke (cardiovascular disease; CVD) result from arterial changes caused by interplay of genetic and environmental factors. Established (e.g. blood pressure and cholesterol) and suspected risk factors (e.g. blood levels of clotting factors, blood markers of glucose control, inflammation and others) are altered years ahead of CVD, but (with the exception of blood pressure and cholesterol) it is uncertain precisely which factors cause the disease and which are altered as a consequence of it, hampering development of new preventative therapies. Some of the genes underpinning CVD and its risk factors have been identified but it is uncertain how best to use the information to help identify those at high risk, or to develop new preventative measures and treatments. Using a technique to simultaneously type 50,000 common gene variants of 2100 genes with known or suspected links to CVD and its known or suspected risk factors, in people from the MRC-funded Whitehall II study, where detailed analyses of the changes in the blood, arteries and heart that predate CVD already exist, my research will help to disentangle the causal pathways (to help develop new preventative treatments), and critically appraise the role and limitations of predictive genetic testing for CVD.</gtr:abstractText><gtr:technicalSummary>Aims and objectives: I aim to test the hypothesis that common genetic variants associated with cardiovascular disease (CVD) and/or related traits and disorders can: (a) help to refine CVD risk stratification, to more effectively target established preventative therapies and; (b) provide new tools to understand causal pathways for CVD, to help develop new preventative interventions relevant to the population as a whole and not just those with a particular genotype. I will use the Whitehall II and collaborating studies to critically appraise the predictive utility and cost-effectiveness of genotypes for risk prediction, and their comparative and incremental utility in relation to established phenotype-based measures of risk. SNPs indexing exogenous exposures/endogenous biomarkers/risk of related disorders (e.g. pre-eclampsia and diabetes) will be applied as tools to test their causal effect on subclinical measures of CVD and, through larger collaborations, on disease risk, using mendelian randomisation.

Design and Methodology: The Whitehall II study of over 10,000 civil servants is recognised for its role in investigation of the determinants of CVD and for the range of detailed and repeated phenotypic and other measures spanning environmental exposures, biomarkers, structural and functional measures of subclinical CVD and disease end-points. Over 6000 Whitehall II participants have been genotyped for 50,000 single-nucleotide polymorphisms (SNPs) from 2100 relevant genes or regions proven or suspected of conferring susceptibility to CVD, or contributing to variance in CVD-related phenotypes using the ITMAT/BROAD/CARE gene centric Cardiochip. The 50k Cardiochip used in Whitehall II is being used by at least 7 other studies in the UK, and at least 9 collaborating studies in the USA so there is an exceptional opportunity to conduct joint analyses of these research questions on a previously unprecedented scale. 

Scientific and medical opportunities. The identification of genotypes relevant to CVD from candidate gene and whole genome studies poses a challenge of how to apply the findings to improve health. The translational opportunities for predicting disease risk and treatment response (pharmacogenetics) are well recognised. The opportunities for causal analysis could be equally important because genotype is unique among naturally-occurring between-individual differences in being determined at random at conception. This could be applied to the development of new drugs for the whole population not just those with a particular genotype, using genetic studies as a natural randomised trial, to more reliably and systematically validate drug targets for CVD and to model their effects.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-27</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-28</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>281444</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Utrecht (UMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Mendelian randomization collaborations</gtr:description><gtr:id>5C8CBF1B-CCBE-458C-9C03-DC782BE3E961</gtr:id><gtr:impact>Lancet paper: MTHFR and stroke
Lancet paper: IL6R and CVD</gtr:impact><gtr:outcomeId>s3UqkbRimVc-2</gtr:outcomeId><gtr:partnerContribution>Established new collaborations
Shared data
Analysed data
Chaired meetings</gtr:partnerContribution><gtr:piContribution>We have established collaborations with international groups to pursue projects in Genetic Epidemiology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Centre for Applied Genomics (CTAG)</gtr:department><gtr:description>Mendelian randomization collaborations</gtr:description><gtr:id>4B0AC5B4-0BB3-4317-9F68-17E301B057AE</gtr:id><gtr:impact>Lancet paper: MTHFR and stroke
Lancet paper: IL6R and CVD</gtr:impact><gtr:outcomeId>s3UqkbRimVc-1</gtr:outcomeId><gtr:partnerContribution>Established new collaborations
Shared data
Analysed data
Chaired meetings</gtr:partnerContribution><gtr:piContribution>We have established collaborations with international groups to pursue projects in Genetic Epidemiology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>2016 European Guidelines on cardiovascular disease prevention in clinical practice</gtr:guidelineTitle><gtr:id>6EB8BE91-5189-4849-A406-DD0367366F9D</gtr:id><gtr:outcomeId>58ca9ec401c0a9.63087694</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>https://academic.oup.com/eurheartj/article/37/29/2315/1748952/2016-European-Guidelines-on-cardiovascular-disease</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CYP2C19 and clopidogrel for CVD prevention</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>3FCCB36A-2D39-46E7-834B-290EB57E30EC</gtr:id><gtr:outcomeId>g7ofxy9eTME</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I developed a series of STATA analysis files that allows the analysis of whether a trait is causally related to disease using a new and emerging technique that employs several single nucleotide polymorphisms together (thereby increasing specificity and power for the intermediate phenotype that you wish to investigate).
This was developed with collaborations at University of Bristol.</gtr:description><gtr:id>25208C98-ACB9-4377-9D3C-51A39FEE5C37</gtr:id><gtr:impact>These are pending.
The analysis files are being used for 2 projects at present:
(i) analysis of height on CVD: this is being undertaken by a group that I am contributing towards
(ii) analysis of causal role of blood lipids on cardiometabolic disease: I am leading this internaltional collaboration using the analysis files that I developed</gtr:impact><gtr:outcomeId>k4jbPUTWHkg</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Multiple instruments for Mendelian randomization</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Traditional Mendelian randomization analyses relies on a linear relationship between the exposure and the outcome. We developed a new approach that allows non-linearity between the exposure and the outcome</gtr:description><gtr:id>4944B53F-BB7E-4B3D-918C-BE99A5AF4B72</gtr:id><gtr:impact>Publication in IJE</gtr:impact><gtr:outcomeId>545a8cc0dffa51.90223473</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Non-linear Mendelian randomization</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/25192829</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>238AB02F-9671-434E-B436-DD07B6552FF7</gtr:id><gtr:title>Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>545a8b89b4e048.36173960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5585DBEB-25E7-4B59-AF78-242061851AD7</gtr:id><gtr:title>An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38da7e290d5e2efd112349d30c252340"><gtr:id>38da7e290d5e2efd112349d30c252340</gtr:id><gtr:otherNames>Shaked A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>58ca84ff578696.93795213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8063F086-FA84-4BD8-B886-72CF76B697FA</gtr:id><gtr:title>Genetic analysis of emerging risk factors in coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c193fa15a2d3f3840583b98fed3d7efe"><gtr:id>c193fa15a2d3f3840583b98fed3d7efe</gtr:id><gtr:otherNames>van Iperen EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>58ca84fe652474.60499043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>898440CB-32CF-4D38-89E1-EF8E251B577F</gtr:id><gtr:title>Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e1cfc3cd2b1aec63bd687e8d3b6377c"><gtr:id>3e1cfc3cd2b1aec63bd687e8d3b6377c</gtr:id><gtr:otherNames>Tragante V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58ca8501ba4569.89622033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EF0DC8F-898D-4796-B577-2FF7E15C1763</gtr:id><gtr:title>Hemiparesis in a 36 year old man.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>58ca8504e221c6.20449790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F10B6C89-40D8-41AD-99E8-AAA17549D14B</gtr:id><gtr:title>The physiological paradox: reframing the polypill as a vaccine for cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Journal of epidemiology and community health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0143-005X</gtr:issn><gtr:outcomeId>pm_13391_21_23729329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05A321A0-7344-4122-A286-D402A88A44D3</gtr:id><gtr:title>Interleukin-6 receptor pathways in abdominal aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa359246572eb8b9a455db895e9ac1e"><gtr:id>baa359246572eb8b9a455db895e9ac1e</gtr:id><gtr:otherNames>Harrison SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>pm_13391_21_23111417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD3E4194-971E-4D56-98E9-361FB3A48FD3</gtr:id><gtr:title>The role of dietary vitamin K in the management of oral vitamin K antagonists.</gtr:title><gtr:parentPublicationTitle>Blood reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-960X</gtr:issn><gtr:outcomeId>58ca850294e070.53737238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEED7D83-4688-42C4-99F2-8755C7A5B9FD</gtr:id><gtr:title>Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>58ca8501877089.40411416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D580713C-86F6-4D4D-B935-2521C7934648</gtr:id><gtr:title>Commentary: Mendelian randomization-inspired causal inference in the absence of genetic data.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdcebffa3bde4cde28943efefbeb46fb"><gtr:id>bdcebffa3bde4cde28943efefbeb46fb</gtr:id><gtr:otherNames>Zuccolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>58ca84ffab3274.77187925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF3E0FA0-E235-4721-9773-C5554FE5BB22</gtr:id><gtr:title>A case for varicella vaccination in the immunosuppressed.</gtr:title><gtr:parentPublicationTitle>BMJ case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1757-790X</gtr:issn><gtr:outcomeId>58ca8505981149.45434973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7FE0047-0838-4763-BC45-6D1789AABE4F</gtr:id><gtr:title>Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85a62af9b18cd088a5109645b5d68f2c"><gtr:id>85a62af9b18cd088a5109645b5d68f2c</gtr:id><gtr:otherNames>Patel RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>doi_55faa1aa1e87c01c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C0EBF1A-2464-43EA-9065-A10DFF13EB0D</gtr:id><gtr:title>Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98232b405a4f3144ac1b3e429a959955"><gtr:id>98232b405a4f3144ac1b3e429a959955</gtr:id><gtr:otherNames>Bragg F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>58ca84ff2af825.54286299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AA1A2F6-91B4-486E-B60E-D68E689B9D23</gtr:id><gtr:title>Genomic research to identify novel pathways in the development of abdominal aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>Cardiology research and practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa359246572eb8b9a455db895e9ac1e"><gtr:id>baa359246572eb8b9a455db895e9ac1e</gtr:id><gtr:otherNames>Harrison SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2090-0597</gtr:issn><gtr:outcomeId>pm_13391_21_22400124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DE8E3F8-C24A-4F0B-A28E-15331CA75938</gtr:id><gtr:title>Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58ca8504345b16.15875768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C9C1A34-B63D-4C4A-B4A3-46146414281C</gtr:id><gtr:title>Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e1cfc3cd2b1aec63bd687e8d3b6377c"><gtr:id>3e1cfc3cd2b1aec63bd687e8d3b6377c</gtr:id><gtr:otherNames>Tragante V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>58ca850066a601.05734772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56D52CC6-0770-4543-ABEE-BB63A65F8131</gtr:id><gtr:title>Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc4f4b732d2e6579d930f536fef7e9f"><gtr:id>bcc4f4b732d2e6579d930f536fef7e9f</gtr:id><gtr:otherNames>Pang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>58ca84fe33f448.01740198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0434668C-3377-40CF-8C1E-03F7FFD66ED9</gtr:id><gtr:title>Long-Term Survival and Freedom From Reintervention After Off-Pump Coronary Artery Bypass Grafting: A Propensity-Matched Study.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ea00e8c8b8cf0624755a4d06e350b50"><gtr:id>8ea00e8c8b8cf0624755a4d06e350b50</gtr:id><gtr:otherNames>Kirmani BH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>58ca84fe941b30.88484685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72D2EA70-DA17-4DB8-BEDE-0BF238C0AE5C</gtr:id><gtr:title>A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>doi_55f984984fe30da6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EA02E07-F761-4819-89AD-7D153E241D55</gtr:id><gtr:title>The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8298237a0c7e333d8706a08172781a8f"><gtr:id>8298237a0c7e333d8706a08172781a8f</gtr:id><gtr:otherNames>Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_13391_21_22421340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D09B62D-607B-41F3-A936-45911C22AA9B</gtr:id><gtr:title>Complex disease genetics: present and future translational applications.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>58ca850545e5e9.86052423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D350F2E-8A71-4C02-8112-B36539505CA7</gtr:id><gtr:title>Serum lipid expression correlates with function and regeneration following living donor liver transplantation.</gtr:title><gtr:parentPublicationTitle>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/075b5e64e16ba749251b890befb42905"><gtr:id>075b5e64e16ba749251b890befb42905</gtr:id><gtr:otherNames>Wolf JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1527-6465</gtr:issn><gtr:outcomeId>58ca8500f077f2.18310904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>385CDA0B-DAAB-44F1-9819-FE3EE2B6C70C</gtr:id><gtr:title>Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/253118228d9c38ca14675e4423a21016"><gtr:id>253118228d9c38ca14675e4423a21016</gtr:id><gtr:otherNames>Asselbergs FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_13391_21_23063622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>255851F2-458C-4E3C-AC15-B51128E102D3</gtr:id><gtr:title>Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a06bcb25009e3fface332b51a9c2bf7b"><gtr:id>a06bcb25009e3fface332b51a9c2bf7b</gtr:id><gtr:otherNames>Shah T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13391_21_23977022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB88FDBE-5DAB-433C-8112-149526DE571E</gtr:id><gtr:title>Putting genomics into practice.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_13391_21_21816737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4CF7C6-3EE6-45C9-BF92-851EE08A0722</gtr:id><gtr:title>CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/021ffb5ed6d319ce5db4ef42f862f0a5"><gtr:id>021ffb5ed6d319ce5db4ef42f862f0a5</gtr:id><gtr:otherNames>Lum DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13391_21_24098545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8DC6F9C-1DEB-4908-83DA-FFDEC0EDFACE</gtr:id><gtr:title>Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d599c8c57723b34879c85806a072e6e"><gtr:id>2d599c8c57723b34879c85806a072e6e</gtr:id><gtr:otherNames>Shah S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>58ca85025df0e5.74364936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E583A2D8-B37C-4181-A8D8-02B7AB5A1C77</gtr:id><gtr:title>Alcohol consumption and cognitive performance: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab7acc252ce55bfb83363870d9acd216"><gtr:id>ab7acc252ce55bfb83363870d9acd216</gtr:id><gtr:otherNames>Kumari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>545a8b2681aee1.11838684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0EED7CC-FAE1-4FF7-A27F-6F59883CC56A</gtr:id><gtr:title>Gene-centric analysis identifies variants associated with interleukin-6 levels and shared pathways with other inflammation markers.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a06bcb25009e3fface332b51a9c2bf7b"><gtr:id>a06bcb25009e3fface332b51a9c2bf7b</gtr:id><gtr:otherNames>Shah T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>58ca850230d437.21212396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A3AD921-D8BE-4906-B3F3-03BA94A00A10</gtr:id><gtr:title>CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_13391_21_22203539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>748A2524-AA28-43C6-AE47-CD51BF5A73FE</gtr:id><gtr:title>Genome wide association studies of abdominal aortic aneurysms-biological insights and potential translation applications.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa359246572eb8b9a455db895e9ac1e"><gtr:id>baa359246572eb8b9a455db895e9ac1e</gtr:id><gtr:otherNames>Harrison SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>58ca850347d7f0.43384340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BF34FC9-209E-4CBA-8657-CD42EDF8CD3E</gtr:id><gtr:title>Cough's postulates.</gtr:title><gtr:parentPublicationTitle>BMJ case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1757-790X</gtr:issn><gtr:outcomeId>58ca8505677252.74694935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50A3BC80-638E-41C4-A8FC-DB5BC239BC71</gtr:id><gtr:title>Cannabis use and risk of schizophrenia: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d290e6d1177dbbb00c919a735e751c8b"><gtr:id>d290e6d1177dbbb00c919a735e751c8b</gtr:id><gtr:otherNames>Vaucher J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>58ca84ff060c38.70806259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8F2CD65-30FF-4314-99D9-95D69AFC46A4</gtr:id><gtr:title>PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70128364005265f5d4f8c162acfb45a2"><gtr:id>70128364005265f5d4f8c162acfb45a2</gtr:id><gtr:otherNames>Schmidt AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>58ca84fec234b3.06958523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1CE3CD5-EC12-417D-9125-ED8E7F81DBA7</gtr:id><gtr:title>Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>pm_13391_21_23916927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76E4692E-251B-45E6-A46C-6C214CBACA7C</gtr:id><gtr:title>Validity of COPD diagnoses reported through nationwide health insurance systems in the People's Republic of China.</gtr:title><gtr:parentPublicationTitle>International journal of chronic obstructive pulmonary disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa4d9535a5669e666cb2f7e8ba49fbed"><gtr:id>aa4d9535a5669e666cb2f7e8ba49fbed</gtr:id><gtr:otherNames>Kurmi OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1176-9106</gtr:issn><gtr:outcomeId>58ca8500c73775.03135305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E09DA3B-2135-4930-BF5F-04F3FA103781</gtr:id><gtr:title>The genetics of coronary heart disease.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd6719eeaadb3d2f606c3b93066661d"><gtr:id>cfd6719eeaadb3d2f606c3b93066661d</gtr:id><gtr:otherNames>Swerdlow DI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>pm_13391_21_22577178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D21190B8-F210-4130-A856-337210238746</gtr:id><gtr:title>Blood pressure loci identified with a gene-centric array.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19b5c8a5850ca34683e1141d5dd4453e"><gtr:id>19b5c8a5850ca34683e1141d5dd4453e</gtr:id><gtr:otherNames>Johnson T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_13391_21_22100073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA919256-8095-4DFB-ABBD-7D97495F0BDE</gtr:id><gtr:title>Fatal lactic acidosis in a kidney transplant recipient on combination antiretroviral therapy after initiation of tacrolimus therapy.</gtr:title><gtr:parentPublicationTitle>Case reports in transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2090-6951</gtr:issn><gtr:outcomeId>58ca85036e32a6.96433305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F37731C-AAB4-4300-8B19-E26100F69F57</gtr:id><gtr:title>Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58ca8502c2aef2.74870866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAB4ED96-1D9F-4E6B-AADF-49F4B8CFF546</gtr:id><gtr:title>Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be0366aaa701f4f91a0c17f91078e7db"><gtr:id>be0366aaa701f4f91a0c17f91078e7db</gtr:id><gtr:otherNames>Talmud PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>24514D8D_724514D8D_7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C2A1D7-3541-475C-B9A9-AF141B078674</gtr:id><gtr:title>An unusual case of dyspnoea.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12bc9aeb86145f845c76dfa365daa980"><gtr:id>12bc9aeb86145f845c76dfa365daa980</gtr:id><gtr:otherNames>Giddings EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58ca8504bbacf1.94279349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1107A7F6-373D-4E50-BE7D-8D5A409C7527</gtr:id><gtr:title>A report on the Genetics of Complex Diseases meeting of the British Atherosclerosis Society, Cambridge, UK, 17-18 September 2009.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>58ca8504041f58.42287158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7269AF2-5F93-4F4A-8908-C51FC531CFAC</gtr:id><gtr:title>Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58ca8504958112.86291208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9C7F866-A215-4090-96A4-488DCCE6E90C</gtr:id><gtr:title>Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cc8aa80998d2dd3dcc4e0b26c3208f"><gtr:id>64cc8aa80998d2dd3dcc4e0b26c3208f</gtr:id><gtr:otherNames>Dale CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5aa8c848511663.19294240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5F3E2A0-7E39-403B-BDFF-4574C24F134E</gtr:id><gtr:title>Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f435dec7cdc4fd944a02c459b769cd83"><gtr:id>f435dec7cdc4fd944a02c459b769cd83</gtr:id><gtr:otherNames>White J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>58ca8500988894.07465553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4C26699-B26C-4D84-986D-3FD08789FD3F</gtr:id><gtr:title>Is the diagnosis at hand?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58ca85046df4b3.80660860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AECF3C2-1C18-407B-976A-D0A4FC4171E7</gtr:id><gtr:title>Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd6719eeaadb3d2f606c3b93066661d"><gtr:id>cfd6719eeaadb3d2f606c3b93066661d</gtr:id><gtr:otherNames>Swerdlow DI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>58ca85001b5bb8.09283657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DD79464-D911-4C1F-9B44-D2D1A8C28AA2</gtr:id><gtr:title>Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>58ca85051905f8.43773743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D537E33-0F25-4C64-AD51-24062E30CE77</gtr:id><gtr:title>Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12a9d7b3e213f83780283d266e35239b"><gtr:id>12a9d7b3e213f83780283d266e35239b</gtr:id><gtr:otherNames>Silverwood RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>doi_55faa1aa1e9efa3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4288F6B-011C-42F6-9310-A154C7A97343</gtr:id><gtr:title>A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6e5c3491b70f339dd3803480860c5f1"><gtr:id>f6e5c3491b70f339dd3803480860c5f1</gtr:id><gtr:otherNames>Sluijs I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5675e359d8e05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B28F14C7-6C8A-4318-8467-3BAA7EED81B4</gtr:id><gtr:title>Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4149d9302cb7c9cd42caa7cf91f81f2"><gtr:id>f4149d9302cb7c9cd42caa7cf91f81f2</gtr:id><gtr:otherNames>van der Laan SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>58ca84ff7c2731.40288120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BF9725A-F1BB-4891-B735-608D21EA88BC</gtr:id><gtr:title>Mendelian randomization of blood lipids for coronary heart disease.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>doi_55faa1aa1e93f862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>974D245C-2F7E-4691-A2D0-9B418E673D2B</gtr:id><gtr:title>Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a2c6bfb5da80ddad2573276d31f7e7b"><gtr:id>0a2c6bfb5da80ddad2573276d31f7e7b</gtr:id><gtr:otherNames>N?esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>58ca85012531c7.04224308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CD1910D-0C44-418E-9975-8409F32F3D18</gtr:id><gtr:title>HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd6719eeaadb3d2f606c3b93066661d"><gtr:id>cfd6719eeaadb3d2f606c3b93066661d</gtr:id><gtr:otherNames>Swerdlow DI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>doi_55f984984feeb6e7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>679BA028-2D29-407A-B786-C6277FB5F2C3</gtr:id><gtr:title>Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a7326af378f5dac3ca9a40954d64f5"><gtr:id>29a7326af378f5dac3ca9a40954d64f5</gtr:id><gtr:otherNames>Khanom AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>58ca85039902d2.21844337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9D1E8FC-A084-4006-866F-9751C4C93F6A</gtr:id><gtr:title>Utility of genetic determinants of lipids and cardiovascular events in assessing risk.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-5002</gtr:issn><gtr:outcomeId>58ca8503c32c15.78455771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F9E3217-20DA-4D01-BFD8-4E1E34B9EAEA</gtr:id><gtr:title>PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cc1ed1f2e7fb7f3bb9542358240dbef"><gtr:id>0cc1ed1f2e7fb7f3bb9542358240dbef</gtr:id><gtr:otherNames>Guardiola M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>doi_55f985985001ad8f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5E6FC13-A5E0-4B7E-8517-32CDE78ABD37</gtr:id><gtr:title>Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.</gtr:title><gtr:parentPublicationTitle>JAMA cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f435dec7cdc4fd944a02c459b769cd83"><gtr:id>f435dec7cdc4fd944a02c459b769cd83</gtr:id><gtr:otherNames>White J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58ca8500420eb2.99452054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A95317F-F4C1-4463-8343-7F425BDD81C4</gtr:id><gtr:title>Evaluation of type 2 diabetes genetic risk variants in Chinese adults: findings from 93,000 individuals from the China Kadoorie Biobank.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5267bc29cc05a0dee915fbee2f1b4c7a"><gtr:id>5267bc29cc05a0dee915fbee2f1b4c7a</gtr:id><gtr:otherNames>Gan W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>58ca84ffe4b0a3.27477465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6258DBD9-664C-4545-A687-904A27CE5CE4</gtr:id><gtr:title>Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58ca8501efa202.36420059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE1EC19F-1AAF-4ADB-8693-876A815A828D</gtr:id><gtr:title>Mendelian randomisation, lipids, and cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa359246572eb8b9a455db895e9ac1e"><gtr:id>baa359246572eb8b9a455db895e9ac1e</gtr:id><gtr:otherNames>Harrison SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_13391_21_22607824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D58E195-5FC2-46E7-B72A-284302C1F6FA</gtr:id><gtr:title>Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856bb22275735c6a7534e465be5a3e8c"><gtr:id>856bb22275735c6a7534e465be5a3e8c</gtr:id><gtr:otherNames>Holmes MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>doi_55f984984ff7ce57</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802432</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>